Shriram ELSS Tax Saver Fund - Growth - Direct Plan

Other Plans and Options
  • (-1.27%)Nav, as on 21-02-2025

  • Previous Nav

  • Net Change on 21-02-2025

  • PersonalFN Rating

  • Category

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the Scheme is to generate income and long-term capital appreciation from a diversified portfolio of predominantly equity and equity-related securities and enable investors to avail the income tax rebate, as permitted from time to time.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Shriram ELSS Tax Saver Fund - Direct Growth -5.68 -10.80 -5.68 10.75 13.07 13.49
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
NIFTY 500 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Shriram ELSS Tax Saver Fund - Direct Growth Jan 25, 2019 Unrated -5.68 10.75 13.07 0.84 47.53
Axis ELSS Tax Saver Fund - Direct Plan - Growth Option Jan 01, 2013 Unrated 9.15 9.41 11.82 0.81 34,496.58
SBI Long Term Equity Fund - DIRECT PLAN -GROWTH Jan 01, 2013 9.80 23.66 22.99 0.95 27,305.51
Mirae Asset ELSS Tax Saver Fund - Direct Plan - Growth Dec 28, 2015 6.37 13.52 18.80 0.57 24,007.47
DSP ELSS Tax Saver Fund - Direct Plan - Growth Dec 31, 2012 11.32 17.71 20.12 0.72 15,985.06
HDFC ELSS Tax saver -Direct Plan - Growth Option Dec 31, 2012 10.11 21.64 20.69 1.10 15,413.45

Fund Holdings as on 31-January-2025

  • Sun Pharmaceutical Industries Ltd.

  • The Indian Hotels Company Ltd.

  • Bharti Airtel Ltd.

  • Dixon Technologies (India) Ltd.

  • Divi's Laboratories Ltd.

  • Lupin Ltd.

  • ICICI Bank Ltd.

  • Mahindra & Mahindra Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Trent Ltd.

  • Info Edge (India) Ltd.

  • Bajaj Holdings & Investment Ltd.

  • Persistent Systems Ltd.

  • Zomato Ltd.

  • PB Fintech Ltd.

  • InterGlobe Aviation Ltd.

  • Tech Mahindra Ltd.

  • Krishna Inst of Medical Sciences Ltd.

  • Clearing Corporation of India Ltd.

  • ITC Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • Infosys Ltd.

  • Voltas Ltd.

  • Net Receivables / (Payables)

  • Hindustan Construction Company Ltd.

  • Coromandel International Ltd.

  • Abbott India Ltd.

  • Eris Lifesciences Ltd.

  • Zydus Lifesciences Ltd.

  • Blue Star Ltd.

  • Aavas Financiers Ltd.

  • Doms Industries Ltd.

  • Coforge Ltd.

  • Oracle Financial Services Software Ltd.

  • Bosch Ltd.

  • IPCA Laboratories Ltd.

  • Gillette India Ltd.

  • V-Guard Industries Ltd.

  • Radico Khaitan Ltd.

  • Aditya Birla Sun Life AMC Ltd.

  • Natco Pharma Ltd.

  • Firstsource Solutions Ltd.

  • Bharat Electronics Ltd.

  • UTI Asset Management Company Ltd.

  • PNB Housing Finance Ltd.

  • Hindustan Aeronautics Ltd.

  • Computer Age Management Services Ltd.

  • Tata Investment Corporation Ltd.

  • AXISCADES Engineering Technologies Ltd.

  • Motilal Oswal Financial Services Ltd.

  • Vijaya Diagnostic Centre Ltd.

  • One 97 Communications Ltd.

  • Himadri Speciality Chemical Ltd.

  • BSE Ltd.

  • ITC Hotels Ltd.

View More

  • Pharmaceuticals & Drugs

  • IT - Software

  • Hospital & Healthcare Services

  • Hotel, Resort & Restaurants

  • Miscellaneous

  • Telecommunication - Service Provider

  • BPO/ITeS

  • Finance - NBFC

  • Air Conditioners

  • Fintech

  • Consumer Durables - Electronics

  • Bank - Private

  • Automobiles - Passenger Cars

  • Retailing

  • Finance - Housing

  • Finance - Asset Management

  • e-Commerce

  • Airlines

  • Defence

  • Cigarettes/Tobacco

  • Engineering - Construction

  • Fertilizers

  • Printing & Stationery

  • Auto Ancillary

  • Household & Personal Products

  • Electric Equipment

  • Breweries & Distilleries

  • Depository Services

  • Finance - Stock Broking

  • Chemicals

  • Finance - Others

View More

Fund Manager

  • Cash

  • Equity

View More

About Shriram ELSS Tax Saver Fund

Scheme Analysis

Shriram ELSS Tax Saver Fund is a Equity - ELSS fund and belongs to Shriram Mutual Fund. It was launched on 25-Jan-2019 and currently has an AUM of ₹47.53 crore. Shriram ELSS Tax Saver Fund is benchmarked against NIFTY 50 - TRI as primary index and NIFTY 500 - TRI as secondary index.

The NAV of Shriram ELSS Tax Saver Fund ended down ₹-0.28(-1.27%)yesterday to ₹21.5851.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The Shriram ELSS Tax Saver Fund is managed by Gargi Bhattacharyya Banerjee and Deepak Ramaraju.

Fund House Contact

Shriram House, No. 4 Burkit Road, T. Nagar, Chennai - 600 017

(033) 2337 3012
info@shriramamc.com
(033) 2337 3014